(Q37987061)

26 August 2017

title

Clofarabine in pediatric acute leukemia: current findings and issues (English)

1 reference

26 August 2017

1 reference

1 reference

Nobuko Hijiya

1

1 reference

26 August 2017

Elly Barry

series ordinal

2

1 reference

26 August 2017

Robert J Arceci

series ordinal

3

1 reference

26 August 2017

language of work or name

1 reference

21 February 2012

1 reference

26 August 2017

published in

Pediatric Blood Cancer

1 reference

26 August 2017

volume

59

1 reference

26 August 2017

issue

3

1 reference

26 August 2017

page(s)

417-422

1 reference

Outcomes for children and adolescents with cancer: challenges for the twenty-first century

26 August 2017

cites work

1 reference

The role of clofarabine in hematologic and solid malignancies--development of a next-generation nucleoside analog

21 January 2018

1 reference

A phase 1 clinical-laboratory study of clofarabine followed by cyclophosphamide for adults with refractory acute leukemias

21 January 2018

1 reference

Clofarabine and cytarabine combination as induction therapy for acute myeloid leukemia (AML) in patients 50 years of age or older

21 January 2018

1 reference

21 January 2018

Clofarabine in leukemia

1 reference

Phase 2 trial of clofarabine in combination with etoposide and cyclophosphamide in pediatric patients with refractory or relapsed acute lymphoblastic leukemia

21 January 2018

1 reference

A multi-center phase I study of clofarabine, etoposide and cyclophosphamide in combination in pediatric patients with refractory or relapsed acute leukemia

21 January 2018

1 reference

Clofarabine, cyclophosphamide and etoposide as single-course re-induction therapy for children with refractory/multiple relapsed acute lymphoblastic leukaemia

21 January 2018

1 reference

Preclinical antitumor activity of 2-chloro-9-(2-deoxy-2-fluoro-beta-D- arabinofuranosyl)adenine (Cl-F-ara-A).

21 January 2018

1 reference

Synthesis and biological activity of 2'-fluoro-2-halo derivatives of 9-.beta.-D-arabinofuranosyladenine

21 January 2018

1 reference

Oral antilymphocyte activity and induction of apoptosis by 2-chloro-2'-arabino-fluoro-2'-deoxyadenosine

21 January 2018

1 reference

Phase I clinical and pharmacology study of clofarabine in patients with solid and hematologic cancers.

21 January 2018

1 reference

Phase 2 clinical and pharmacologic study of clofarabine in patients with refractory or relapsed acute leukemia

21 January 2018

1 reference

European development of clofarabine as treatment for older patients with acute myeloid leukemia considered unsuitable for intensive chemotherapy

21 January 2018

1 reference

Clofarabine, a novel nucleoside analog, is active in pediatric patients with advanced leukemia

21 January 2018

1 reference

Results of a phase 1-2 study of clofarabine in combination with cytarabine (ara-C) in relapsed and refractory acute leukemias

21 January 2018

1 reference

Clofarabine combinations as acute myeloid leukemia salvage therapy

21 January 2018

1 reference

Reinduction platform for children with first marrow relapse of acute lymphoblastic Leukemia: A Children's Oncology Group Study[corrected]

21 January 2018

1 reference

Discovery and development of clofarabine: a nucleoside analogue for treating cancer

21 January 2018

1 reference

Oral clofarabine in the treatment of patients with higher-risk myelodysplastic syndrome

21 January 2018

1 reference

Epigenetic silencing of BIM in glucocorticoid poor-responsive pediatric acute lymphoblastic leukemia, and its reversal by histone deacetylase inhibition.

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1002/PBC.24112

1 reference

26 August 2017

1 reference